Home CEPI, THSTI and Panacea Biotec to develop Beta-coronavirus vaccines CEPI, THSTI and Panacea Biotec to develop Beta-coronavirus vaccines

CEPI, THSTI and Panacea Biotec to develop Beta-coronavirus vaccines

CEPI, THSTI and Panacea Biotec to develop Beta-coronavirus vaccines

CEPI will partner with a consortium comprised of the Translational Health Science and Technology Institute (THSTI) and Panacea Biotec to develop vaccine candidates that could provide broad protection against SARS-COV-2variants and other Beta-Coronaviruses.


Print pagePDF pageEmail page

PRESS RELEASE